A global medical device manufacturer partnered with Roots Analysis to conduct product launch monitoring across North America and Europe, refining its launch strategy for a next-generation ready-to-use (RTU) prefilled syringe platform.
Let's TalkAs the platform approached launch stage, the client lacked clear visibility into how rapidly pharmaceutical companies would transition towards next-generation RTU prefilled syringes. To address this uncertainty, the client sought structured monitoring of competitor launch activities to better anticipate adoption trends.
The client wanted clarity on various partnership models adopted by their industry peers, including supply agreements and CDMO collaborations, to determine how strategic alliances could strengthen their launch strategy and market positioning.
The growing market shift towards drug-device combination products introduced strategic uncertainty. The leadership team needed clarity on whether integrated platforms would accelerate ahead of standalone prefilled syringe offerings and how this evolution could influence differentiation and long-term positioning.
